A Double-blind, Randomized, Placebo-controlled, Two-period Crossover Trial to Assess the Effects of 4 g/d Prescription Omega-3 Ethyl Esters on Low-density Lipoprotein Cholesterol in Subjects With Primary Hypercholesterolemia
Latest Information Update: 13 May 2024
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Hypercholesterolaemia
- Focus Biomarker; Therapeutic Use
Most Recent Events
- 11 May 2024 Status changed from recruiting to completed.
- 29 Jan 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 23 Sep 2009 Planned initiation date changed from 1 Jul 2009 to 1 Jan 2010 as reported by ClinicalTrials.gov.